netFormulary
 Report : A-Z HCD items in Formulary 29/05/2020 13:44:27
[Back]
 
Section Status HCD Name
05.03.01 Restricted Use Cancer Drugs Fund Abacavir Ziagen®
05.03.01 Restricted Use Cancer Drugs Fund Abacavir and Lamivudine 
05.03.01 Restricted Use Cancer Drugs Fund Abacavir and Lamivudine and Zidovudine Trizivir®
10.01.03 Restricted Use Cancer Drugs Fund Abatacept Orencia®
08.01.05 Formulary Cancer Drugs Fund Abemaciclib Verzenios®
08.03.04.02 Restricted Use Cancer Drugs Fund Abiraterone Zytiga®
01.05.03 Restricted Use Cancer Drugs Fund Adalimumab 
10.01.03 Restricted Use Cancer Drugs Fund Adalimumab 
11.04.02 Restricted Use Cancer Drugs Fund Adalimumab  
13.05.03 Restricted Use Cancer Drugs Fund Adalimumab 
05.03.03.01 Restricted Use Cancer Drugs Fund Adefovir Dipivoxil Hepsera®
08.01.05 Restricted Use Cancer Drugs Fund Aflibercept Zaltrap®
11.08.02 Restricted Use Cancer Drugs Fund Aflibercept Eylea®
09.08.01 Non Formulary Cancer Drugs Fund Agalsidase Alfa and Beta Fabrazyme®
09.08.01 Non Formulary Cancer Drugs Fund Agalsidase Alfa and Beta Replagal®
02.11 Restricted Use Cancer Drugs Fund Albutrepenonacog alfa Idelvion®
08.02.04 Non Formulary Cancer Drugs Fund Aldesleukin Proleukin®
08.02.03 Formulary Cancer Drugs Fund Alemtuzumab MabCampath®
09.08.01 Non Formulary Cancer Drugs Fund Alglucosidase Alfa Myozyme®
13.05.01 Restricted Use Cancer Drugs Fund Alitretinoin Toctino®
02.05.01 Non Formulary Cancer Drugs Fund Ambrisentan 
10.02.01 Non Formulary Cancer Drugs Fund Amifampridine Firdapse
05.02 Restricted Use Cancer Drugs Fund Amphotericin Abelcet®
05.02 Restricted Use Cancer Drugs Fund Amphotericin AmBisome®
10.01.03 Restricted Use Cancer Drugs Fund Anakinra Kineret®
05.02.04 Restricted Use Cancer Drugs Fund Anidulafungin Ecalta®
02.11 Restricted Use Cancer Drugs Fund Antithrombin III Kybernin®
09.01.03 Non Formulary Cancer Drugs Fund Antithymocyte Immunoglobulin (Equine) 
08.02.02 Restricted Use Cancer Drugs Fund Antithymocyte immunoglobulin (rabbit)  Thymoglobuline®
13.05.03 Restricted Use Cancer Drugs Fund Apremilast Otezla®
08.01.05 Restricted Use Cancer Drugs Fund Arsenic Trioxide 
09.08.01 Non Formulary Cancer Drugs Fund Asfotase alfa Strensiq®
10.02 Restricted Use Cancer Drugs Fund Ataluren Translarna®
05.03.01 Restricted Use Cancer Drugs Fund Atazanavir 
05.03.01 Restricted Use Cancer Drugs Fund Atazanavir sulfate and cobicistat Evotaz®
08.01.05 Restricted Use Cancer Drugs Fund Atezolizumab Tecentriq®
08.02.03 Restricted Use Cancer Drugs Fund Avelumab Bavencio®
08.01.05 Restricted Use Cancer Drugs Fund Axitinib Inlyta®
08.01.03 Restricted Use Cancer Drugs Fund Azacitidine Vidaza®
05.01.02.03 Restricted Use Cancer Drugs Fund Aztreonam nebuliser solution Cayston®
10.01.03 Restricted Use Cancer Drugs Fund Baricitinib Olumiant®
08.02.02 Formulary Cancer Drugs Fund Basiliximab Simulect®
05.01.09 Restricted Use Cancer Drugs Fund Bedaquiline Sirturo®
08.02.02 Non Formulary Cancer Drugs Fund Belatacept Nulojix®
10.01 Restricted Use Cancer Drugs Fund Belimumab Benlysta®
08.01.01 Restricted Use Cancer Drugs Fund Bendamustine 
03.05.02 Non Formulary Cancer Drugs Fund Beractant Survanta®
08.01.05 Restricted Use Cancer Drugs Fund Bevacizumab Avastin®
05.03.01 Restricted Use Cancer Drugs Fund Bictegravir, emtricitabine and tenofovir alafenamide Biktarvy®
08.02 Restricted Use Cancer Drugs Fund Blinatumomab Blincyto®
05.03.03.02 Non Formulary Cancer Drugs Fund Boceprevir Victrelis®
08.01.05 Formulary Cancer Drugs Fund Bortezomib 
02.05.01 Formulary Cancer Drugs Fund Bosentan 
08.01.05 Restricted Use Cancer Drugs Fund Bosutinib Bosulif®
04.07.04.02 Formulary Cancer Drugs Fund Botulinum Toxin Type A botox®
08.01.05 Restricted Use Cancer Drugs Fund Brentuximab vedotin Adcetris®
13.05.02 Restricted Use Cancer Drugs Fund Brodalumab Kyntheum®
03.04.03 Formulary Cancer Drugs Fund C1 esterase inhibitor Cinryze®
03.04.03 Restricted Use Cancer Drugs Fund C1 Esterase Inhibitor Berinert®
08.01.05 Restricted Use Cancer Drugs Fund Cabazitaxel Jevtana®
08.01.05 Restricted Use Cancer Drugs Fund Cabozantinib Cabometyx®
08.01.05 Restricted Use Cancer Drugs Fund Cabozantinib Cometriq®
08.02.04 Non Formulary Cancer Drugs Fund Canakinumab Ilaris®
08.01.05 Restricted Use Cancer Drugs Fund Carfilzomib Kyprolis®
09.08.01 Restricted Use Cancer Drugs Fund Carglumic Acid Carbaglu®
05.02.04 Restricted Use Cancer Drugs Fund Caspofungin 
02.11 Non Formulary Cancer Drugs Fund Catridecacog NovoThirteen®
08.02.04 Formulary Cancer Drugs Fund Cemiplimab Libtayo ®
08.01.05 Restricted Use Cancer Drugs Fund Ceritinib Zykadia
10.01.03 Restricted Use Cancer Drugs Fund Certolizumab Pegol Cimzia®
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux®
09.08.01 Non Formulary Cancer Drugs Fund Chenodeoxycholic acid Xenbilox®
09.08.01 Non Formulary Cancer Drugs Fund Chenodeoxycholic acid Leadiant biosciences
01.09.01 Non Formulary Cancer Drugs Fund Cholic acid Orphacol®
01.09.01 Non Formulary Cancer Drugs Fund Cholic acid Kolbam®
08.02.02 Formulary Cancer Drugs Fund Ciclosporin 
05.03.02.02 Restricted Use Cancer Drugs Fund Cidofovir infusion 
09.05.01.02 Restricted Use Cancer Drugs Fund Cinacalcet Mimpara®
08.01.03 Formulary Cancer Drugs Fund Cladribine 
08.01.03 Formulary Cancer Drugs Fund Cladribine Mavenclad®
08.01.03 Restricted Use Cancer Drugs Fund Clofarabine 
05.03.01 Restricted Use Cancer Drugs Fund Cobicistat Tybost®
04.09.01 Restricted Use Cancer Drugs Fund Co-Careldopa Duodopa®
09.05.02.02 Non Formulary Cancer Drugs Fund Colestilan BindRen®
05.01.07 Restricted Use Cancer Drugs Fund Colistimethate Promixin®
05.01.07 Formulary Cancer Drugs Fund Colistimethate for nebulisation Colomycin®
05.01.07 Restricted Use Cancer Drugs Fund Colistimethate inhaler Colobreathe®
10.03.01 Non Formulary Cancer Drugs Fund Collagenase Xiapex®
03.04.03 Non Formulary Cancer Drugs Fund Conestat Alfa Ruconest®
08.01.05 Restricted Use Cancer Drugs Fund Crizotinib Xalkori®
08.01.05 Restricted Use Cancer Drugs Fund Dabrafenib Tafinlar®
05.03.03.02 Non Formulary Cancer Drugs Fund Daclatasvir  Daklinza®
08.02.04 Restricted Use Cancer Drugs Fund Daclizumab Zinbryta®
08.01.05 Formulary Cancer Drugs Fund Dacomitinib monohydrate Vizimpro®
08.01.05 Restricted Use Cancer Drugs Fund Daratumumab Darzalex®
09.01.03 Restricted Use Cancer Drugs Fund Darbepoetin Alfa Aranesp®
05.03.01 Restricted Use Cancer Drugs Fund Darunavir 
05.03.01 Restricted Use Cancer Drugs Fund Darunavir and Cobicistat Rezolsta®
05.03.03.02 Restricted Use Cancer Drugs Fund Dasabuvir Exviera®
08.01.05 Restricted Use Cancer Drugs Fund Dasatinib Sprycel®
20 Formulary Cancer Drugs Fund DAUNORUBICIN saline pre-filled syringe 
08.01.03 Non Formulary Cancer Drugs Fund Decitabine Dacogen®
09.01.03 Restricted Use Cancer Drugs Fund Deferasirox Exjade®
09.01.03 Formulary Cancer Drugs Fund Deferiprone Ferriprox®
02.10.02 Formulary Cancer Drugs Fund Defibrotide 
20 Non Formulary Cancer Drugs Fund DEFIBROTIDE Capsules 400 mg 
05.01.09 Non Formulary Cancer Drugs Fund Delamanid Deltyba®
09.01.03 Formulary Cancer Drugs Fund Desferrioxamine Mesilate 
11.04.01 Restricted Use Cancer Drugs Fund Dexamethasone intravitreal implant Ozurdex®
08.01 Restricted Use Cancer Drugs Fund Dexrazoxane Savene®
08.01 Restricted Use Cancer Drugs Fund Dexrazoxane Cardioxane®
05.03.01 Restricted Use Cancer Drugs Fund Didanosine Videx®
02.01.01 Restricted Use Cancer Drugs Fund Digoxin specific antibody fragments Digifab®
18 Restricted Use Cancer Drugs Fund Digoxin specific antibody fragments Digifab®
08.02.04 Restricted Use Cancer Drugs Fund Dimethyl fumarate Tecfidera®
13.05.02 Restricted Use Cancer Drugs Fund Dimethyl Fumarate  
08.02.04 Restricted Use Cancer Drugs Fund Dinutuximab beta 
05.03.01 Formulary Cancer Drugs Fund Dolutegravir 
05.03.01 Formulary Cancer Drugs Fund Dolutegravir, abacavir & lamivudine Triumeq®
05.03.01 Restricted Use Cancer Drugs Fund Doravirine Pifeltro®
05.03.01 Restricted Use Cancer Drugs Fund Doravirine and Lamivudine and Tenofovir disoproxil Delstrigo®
03.07 Formulary Cancer Drugs Fund Dornase Alfa Pulmozyme®
08.01.02 Restricted Use Cancer Drugs Fund Doxorubicin Caelyx®
13.05.03 Restricted Use Cancer Drugs Fund Dupilumab Dupixent®
09.01.03 Restricted Use Cancer Drugs Fund Eculizumab 
05.03.01 Restricted Use Cancer Drugs Fund Efavirenz Sustiva®
02.11 Restricted Use Cancer Drugs Fund Efmoroctocog alfa Elocta®
02.11 Restricted Use Cancer Drugs Fund Eftrenonacog alfa Alprolix®
05.03.03.02 Restricted Use Cancer Drugs Fund Elbasvir/Grazoprevir Zepatier®
09.08.01 Non Formulary Cancer Drugs Fund Eliglustat Cerdelga®
09.08.01 Non Formulary Cancer Drugs Fund Elosulfase alfa Vimizim®
09.01.04 Restricted Use Cancer Drugs Fund Eltrombopag Revolade®
02.11 Restricted Use Cancer Drugs Fund Emicizumab Hemlibra®
05.03.01 Restricted Use Cancer Drugs Fund Emtricitabine Emtriva®
05.03.01 Restricted Use Cancer Drugs Fund Emtricitabine + rilpivirine + tenofovir alafenamide Odefsey®
05.03.01 Restricted Use Cancer Drugs Fund Emtricitabine + tenofovir alafenamide Descovy®
05.03.01 Restricted Use Cancer Drugs Fund Emtricitabine 200mg, Rilpivirine 25mg and Tenofovir 245mg Eviplera®
08.01.05 Formulary Cancer Drugs Fund Encorafenib Braftovi®
05.03.01 Formulary Cancer Drugs Fund Enfuvirtide Fuzeon®
05.03.03.01 Restricted Use Cancer Drugs Fund Entecavir 
08.03.04.02 Restricted Use Cancer Drugs Fund Enzalutamide Xtandi®
09.01.03 Restricted Use Cancer Drugs Fund Epoetin alfa Eprex®
09.01.03 Restricted Use Cancer Drugs Fund Epoetin beta NeoRecormon®
02.08.01 Restricted Use Cancer Drugs Fund Epoprostenol Flolan®
20 Non Formulary Cancer Drugs Fund Eptotermin Alfa  Osigraft®
08.01.05 Restricted Use Cancer Drugs Fund Eribulin Halaven®
08.01.05 Restricted Use Cancer Drugs Fund Erlotinib Tarceva®
10.01.03 Restricted Use Cancer Drugs Fund Etanercept Enbrel®
13.05.03 Formulary Cancer Drugs Fund Etanercept Enbrel®
05.03.01 Restricted Use Cancer Drugs Fund Etravirine Intelence®
08.01.05 Restricted Use Cancer Drugs Fund Everolimus Votubia®
08.01.05 Restricted Use Cancer Drugs Fund Everolimus Afinitor®
08.02.02 Non Formulary Cancer Drugs Fund Everolimus Certican®
02.11 Restricted Use Cancer Drugs Fund Factor Eight Inhibitor Bypassing Fraction Feiba®
02.11 Non Formulary Cancer Drugs Fund Factor IX Fraction, Dried 
02.11 Restricted Use Cancer Drugs Fund Factor VIIa (Recombinant), Eptacog alfa NovoSeven®
02.11 Restricted Use Cancer Drugs Fund Factor VIII NovoEight®
02.11 Restricted Use Cancer Drugs Fund Factor VIII - Von willebrand factor Wilate®
02.11 Restricted Use Cancer Drugs Fund Factor VIII - Von willebrand factor Type 8Y®
02.11 Restricted Use Cancer Drugs Fund Factor VIII + von Willebrand factor Voncento®
02.11 Non Formulary Cancer Drugs Fund Factor VIII Fraction, Dried 
02.11 Non Formulary Cancer Drugs Fund Factor VIII Inhibitor Bypassing Fraction 
02.11 Non Formulary Cancer Drugs Fund Factor XIII Fraction, Dried 
08.02.04 Non Formulary Cancer Drugs Fund Fampridine 
05.01.07 Formulary Cancer Drugs Fund Fidaxomicin Dificlir®
09.01.06 Formulary Cancer Drugs Fund Filgrastim Nivestim®
09.01.06 Restricted Use Cancer Drugs Fund Filgrastim Neupogen®
08.02.04 Restricted Use Cancer Drugs Fund Fingolimod 
11.04.01 Restricted Use Cancer Drugs Fund Fluocinolone intravitreal implant Iluvien®
18 Restricted Use Cancer Drugs Fund Fomepizole 
05.03.01 Restricted Use Cancer Drugs Fund Fosamprenavir Telzir®
05.03.02.02 Restricted Use Cancer Drugs Fund Foscarnet Sodium Foscavir®
05.03.02.02 Restricted Use Cancer Drugs Fund Ganciclovir 
08.01.05 Restricted Use Cancer Drugs Fund Gefitinib 
08.01.05 Restricted Use Cancer Drugs Fund Gilteritinib  Xospata®
08.02.04 Formulary Cancer Drugs Fund Glatiramer Acetate 
05.03.03.02 Formulary Cancer Drugs Fund Glecaprevir/Pibrentasvir Maviret®
18 Restricted Use Cancer Drugs Fund Glucarpidase Carboxypeptidase
01.05.03 Restricted Use Cancer Drugs Fund Golimumab Simponi®
10.01.03 Restricted Use Cancer Drugs Fund Golimumab Simponi®
13.05.03 Restricted Use Cancer Drugs Fund Guselkumab Tremfya®
09.08.02 Non Formulary Cancer Drugs Fund Haem Arginate Normosang®
02.11 Restricted Use Cancer Drugs Fund Human Fibrinogen Riastap®
08.01.05 Restricted Use Cancer Drugs Fund Ibrutinib Imbruvica®
03.04.03 Restricted Use Cancer Drugs Fund Icatibant Firazyr®
02.05.01 Formulary Cancer Drugs Fund Iloprost injection  
08.01.05 Restricted Use Cancer Drugs Fund Imatinib 
09.08.01 Non Formulary Cancer Drugs Fund Imiglucerase Cerezyme®
05.03.01 Non Formulary Cancer Drugs Fund Indinavir Crixivan®
01.05.03 Restricted Use Cancer Drugs Fund Infliximab Remicade®
01.05.03 Non Formulary Cancer Drugs Fund Infliximab Inflectra®
01.05.03 Restricted Use Cancer Drugs Fund Infliximab Remsima®
10.01.03 Restricted Use Cancer Drugs Fund Infliximab Remicade®
13.05.03 Formulary Cancer Drugs Fund Infliximab Remicade®
08.01.05 Restricted Use Cancer Drugs Fund Inotuzumab Ozogamicin  Besponsa®
08.02.04 Non Formulary Cancer Drugs Fund Interferon Alfa Viraferon®
08.02.04 Formulary Cancer Drugs Fund Interferon Alfa-2a Roferon-A®
08.02.04 Non Formulary Cancer Drugs Fund Interferon Alfa-2b IntronA®
08.02.04 Non Formulary Cancer Drugs Fund Interferon Beta Proleukin®
08.02.04 Restricted Use Cancer Drugs Fund Interferon Beta-1a Avonex®
08.02.04 Restricted Use Cancer Drugs Fund Interferon Beta-1a Rebif®
08.02.04 Restricted Use Cancer Drugs Fund Interferon beta-1b Extavia®
08.02.04 Non Formulary Cancer Drugs Fund Interferon Beta-1b Betaferon®
08.01.05 Restricted Use Cancer Drugs Fund Ipilimumab Yervoy®
03.07 Restricted Use Cancer Drugs Fund Ivacaftor 
13.05.02 Restricted Use Cancer Drugs Fund Ixekizumab Taltz®
05.03.01 Restricted Use Cancer Drugs Fund Lamivudine Zeffix®
05.03.01 Restricted Use Cancer Drugs Fund Lamivudine Epivir®
05.03.01 Non Formulary Cancer Drugs Fund Lamivudine & raltegravir Dutrebis®
03.04.03 Restricted Use Cancer Drugs Fund Lanadelumab 
08.03.04.03 Restricted Use Cancer Drugs Fund Lanreotide Somatuline Autogel®
09.05.02.02 Restricted Use Cancer Drugs Fund Lanthanum Fosrenol ®
08.01.05 Restricted Use Cancer Drugs Fund Lapatinib Tyverb®
09.08.01 Non Formulary Cancer Drugs Fund Laronidase Aldurazyme®
05.03.03.02 Restricted Use Cancer Drugs Fund Ledipasvir and Sofosbuvir Harvoni®
08.02.04 Restricted Use Cancer Drugs Fund Lenalidomide 
09.01.06 Restricted Use Cancer Drugs Fund Lenograstim Granocyte®
08.01.05 Restricted Use Cancer Drugs Fund Lenvatinib Lenvima®
08.01.05 Restricted Use Cancer Drugs Fund Lenvatinib Kisplyx®
05.03.02.02 Formulary Cancer Drugs Fund Letermovir Prevymis®
09.08.01 Formulary Cancer Drugs Fund Levocarnitine Carnitor®
05.01.12 Restricted Use Cancer Drugs Fund Levofloxacin Quinsair®
08.01.02 Restricted Use Cancer Drugs Fund Liposomal Cytarabine-Daunorubicin Vyxeos®
02.12 Non Formulary Cancer Drugs Fund Lomitapide Lojuxta®
05.03.01 Restricted Use Cancer Drugs Fund Lopinavir and Ritonavir Kaletra®
09.01.04 Restricted Use Cancer Drugs Fund Lusutrombopag Mulpleo®
08.03.04.03 Restricted Use Cancer Drugs Fund Lutetium (177Lu) oxodotreotide Lutathera®
02.05.01 Non Formulary Cancer Drugs Fund Macitentan Opsumit®
03.07 Restricted Use Cancer Drugs Fund Mannitol inhalation Bronchitol ®
05.03.01 Formulary Cancer Drugs Fund Maraviroc Celsentri®
06.07.04 Non Formulary Cancer Drugs Fund Mecasermin Increlex®
09.08.01 Non Formulary Cancer Drugs Fund Mercaptamine Cystagon®
09.08.01 Formulary Cancer Drugs Fund Mercaptamine (cysteamine) eye drops  
09.01.03 Restricted Use Cancer Drugs Fund Methoxy Polyethylene Glycol-Epoetin Beta Mircera®
05.02.04 Restricted Use Cancer Drugs Fund Micafungin Mycamine®
08.01.05 Restricted Use Cancer Drugs Fund Midostaurin Rydapt®
09.08.01 Non Formulary Cancer Drugs Fund Migalastat Galafold®
09.08.01 Non Formulary Cancer Drugs Fund Miglustat Zavesca®
02.11 Restricted Use Cancer Drugs Fund Moroctocog alfa Refacto®
08.02.01 Restricted Use Cancer Drugs Fund Mycophenolate Mofetil 
08.02.04 Formulary Cancer Drugs Fund Natalizumab Tysabri®
08.01.05 Non Formulary Cancer Drugs Fund Necitumumab Portrazza®
08.01.03 Restricted Use Cancer Drugs Fund Nelarabine Atriance®
05.03.01 Non Formulary Cancer Drugs Fund Nelfinavir Viracept®
05.03.01 Restricted Use Cancer Drugs Fund Nevirapine 
08.01.05 Restricted Use Cancer Drugs Fund Nilotinib Tasigna®
03.11 Restricted Use Cancer Drugs Fund Nintedanib Ofev®
03.11 Restricted Use Cancer Drugs Fund Nintedanib Vargatef®
08.02.04 Restricted Use Cancer Drugs Fund Niraparib Zejula®
20 Restricted Use Cancer Drugs Fund Nitazoxanide 
08.02.04 Restricted Use Cancer Drugs Fund Nivolumab Opdivo®
02.11 Restricted Use Cancer Drugs Fund Nonacog alfa BeneFIX®
14.05.01 Restricted Use Cancer Drugs Fund Normal immunoglobulin for Intramuscular use 
14.05.01 Restricted Use Cancer Drugs Fund Normal immunoglobulin for Intravenous use 
14.05.01 Restricted Use Cancer Drugs Fund Normal immunoglobulin for Subcutaneous use 
01.09.01 Restricted Use Cancer Drugs Fund Obeticholic acid Ocaliva®
08.02.03 Restricted Use Cancer Drugs Fund Obinutuzumab Gazyvaro ®
08.02.03 Restricted Use Cancer Drugs Fund Ocrelizumab Ocrevus®
11.08.02 Restricted Use Cancer Drugs Fund Ocriplasmin Jetrea®
02.11 Restricted Use Cancer Drugs Fund Octocog alfa Kogenate®
02.11 Restricted Use Cancer Drugs Fund Octocog alfa Advate®
08.03.04.03 Formulary Cancer Drugs Fund Octreotide Sandostatin®
08.03.04.03 Formulary Cancer Drugs Fund Octreotide Sandostatin Lar®
08.02.03 Non Formulary Cancer Drugs Fund Ofatumumab Arzerra®
08.02.04 Restricted Use Cancer Drugs Fund Olaparib Lynparza®
08.01.05 Non Formulary Cancer Drugs Fund Olaratumab Lartruvo®
03.04.02 Restricted Use Cancer Drugs Fund Omalizumab Xolair®
05.03.03.02 Restricted Use Cancer Drugs Fund Ombitasvir/ paritaprevir/ ritonavir Viekirax®
08.01.05 Restricted Use Cancer Drugs Fund Paclitaxel - Albumin Bound Formulation Abraxane®
08.03.04.01 Formulary Cancer Drugs Fund Palbociclib Ibrance®
05.03.05 Restricted Use Cancer Drugs Fund Palivizumab Synagis®
08.01.05 Restricted Use Cancer Drugs Fund Panitumumab Vectibix®
08.01.05 Formulary Cancer Drugs Fund Panobinostat Farydak®
06.06.01 Non Formulary Cancer Drugs Fund Parathyroid Hormone Preotact®
06.05 Non Formulary Cancer Drugs Fund Pasireotide 
08.01.05 Restricted Use Cancer Drugs Fund Pazopanib Votrient®
11.08.02 Non Formulary Cancer Drugs Fund Pegaptanib Sodium Macugen®
09.01.06 Non Formulary Cancer Drugs Fund Pegfilgrastim Neulasta®
08.02.04 Non Formulary Cancer Drugs Fund Peginterferon Alfa PegIntron®
08.02.04 Non Formulary Cancer Drugs Fund Peginterferon Alfa ViraferonPeg®
08.02.04 Formulary Cancer Drugs Fund Peginterferon Alfa-2a Pegasys®
08.02.04 Restricted Use Cancer Drugs Fund Peginterferon Beta-1a Plegridy®
06.05.01 Restricted Use Cancer Drugs Fund Pegvisomant Somavert®
08.01.05 Restricted Use Cancer Drugs Fund Pembrolizumab Keytruda®
08.01.03 Restricted Use Cancer Drugs Fund Pemetrexed Alimta®
08.01.05 Restricted Use Cancer Drugs Fund Pertuzumab Perjeta®
03.11 Restricted Use Cancer Drugs Fund Pirfenidone Esbriet®
08.01.02 Restricted Use Cancer Drugs Fund Pixantrone 
09.01.07 Restricted Use Cancer Drugs Fund Plerixafor Mozobil®
08.02.04 Restricted Use Cancer Drugs Fund Pomalidomide Imnovid®
08.01.05 Restricted Use Cancer Drugs Fund Ponatinib Iclusig®
03.05.02 Formulary Cancer Drugs Fund Poractant Alfa Curosurf®
05.02 Restricted Use Cancer Drugs Fund Posaconazole (IV) Noxafil®
05.02 Restricted Use Cancer Drugs Fund Posaconazole (oral) Noxafil®
02.11 Restricted Use Cancer Drugs Fund Protein C Concentrate Ceprotin®
02.11 Restricted Use Cancer Drugs Fund Prothrombin Complex Concentrate  Octaplex®
08.03.04.02 Restricted Use Cancer Drugs Fund Radium-223 dichloride 
05.03.01 Formulary Cancer Drugs Fund Raltegravir Isentress ®
08.01.05 Non Formulary Cancer Drugs Fund Ramucirumab Cyramza®
11.08.02 Formulary Cancer Drugs Fund Ranibizumab Lucentis®
10.01.04 Restricted Use Cancer Drugs Fund Rasburicase Fastertec®
08.01.05 Restricted Use Cancer Drugs Fund Regorafenib Stivarga®
05.03.05 Restricted Use Cancer Drugs Fund Ribavirin 
08.03.04.01 Restricted Use Cancer Drugs Fund Ribociclib Kisqali®
05.03.01 Restricted Use Cancer Drugs Fund Rilpivirine hydrochloride Edurant®
04.09.03 Restricted Use Cancer Drugs Fund Riluzole 
02.05.01 Non Formulary Cancer Drugs Fund Riociguat Adempas®
13.05.02 Formulary Cancer Drugs Fund Risankizumab Skyrizi®
05.03.01 Restricted Use Cancer Drugs Fund Ritonavir 
08.02.03 Restricted Use Cancer Drugs Fund Rituximab MabThera®
08.02.03 Restricted Use Cancer Drugs Fund Rituximab Truxima®
08.02.03 Restricted Use Cancer Drugs Fund Rituximab MabThera®
10.01.03 Restricted Use Cancer Drugs Fund Rituximab Truxima®
10.01.03 Restricted Use Cancer Drugs Fund Rituximab  MabThera®
09.01.04 Restricted Use Cancer Drugs Fund Romiplostim Nplate®
08.02.04 Restricted Use Cancer Drugs Fund Rucaparib Rubraca®
08.01.05 Restricted Use Cancer Drugs Fund Ruxolitinib Jakavi®
09.04.01 Formulary Cancer Drugs Fund Sapropterin Dihydrochloride  Kuvan®
05.03.01 Restricted Use Cancer Drugs Fund Saquinavir Invirase®
10.01.03 Restricted Use Cancer Drugs Fund Sarilumab Kevzara®
13.05.03 Restricted Use Cancer Drugs Fund Secukinumab Cosentyx®
09.05.02.02 Restricted Use Cancer Drugs Fund Sevelamer Carbonate 
09.05.02.02 Non Formulary Cancer Drugs Fund Sevelamer Hydrochloride  Renagel®
02.05.01 Formulary Cancer Drugs Fund Sildenafil Revatio®
05.03.03.02 Non Formulary Cancer Drugs Fund Simeprevir Olysio®
02.11 Restricted Use Cancer Drugs Fund Simoctocog alfa Nuwiq®
20 Non Formulary Cancer Drugs Fund Sipuleucel- T 
08.02.02 Formulary Cancer Drugs Fund Sirolimus Rapamune®
04.01.01 Restricted Use Cancer Drugs Fund Sodium Oxybate Xyrem®
05.03.03.02 Restricted Use Cancer Drugs Fund Sofosbuvir Sovaldi®
05.03.03.02 Restricted Use Cancer Drugs Fund Sofosbuvir and Velpatasvir Epclusa®
05.03.03.02 Restricted Use Cancer Drugs Fund Sofosbuvir, Velpatasvir and Voxilaprevir  Vosevi®
06.05.01 Restricted Use Cancer Drugs Fund Somatropin 
08.01.05 Restricted Use Cancer Drugs Fund Sorafenib Nexavar®
05.03.01 Non Formulary Cancer Drugs Fund Stavudine Zerit®
08.01.05 Restricted Use Cancer Drugs Fund Sunitinib Sutent®
02.11 Restricted Use Cancer Drugs Fund Susoctocog alfa Obizur®
20 Non Formulary Cancer Drugs Fund Taribavirin 
01.04.02 Non Formulary Cancer Drugs Fund Teduglutide Revestive®
05.03.03.02 Non Formulary Cancer Drugs Fund Telaprevir Incivo®
08.01.05 Formulary Cancer Drugs Fund Temozolomide Temodal®
08.01.05 Restricted Use Cancer Drugs Fund Temsirolimus Torisel®
05.03.01 Restricted Use Cancer Drugs Fund Tenofovir 245mg, Efavirenz 600mg and Emtricitabine 200mg 
05.03.01 Restricted Use Cancer Drugs Fund Tenofovir alafenamide, elvitegravir, cobicistat & emtricitabine Genvoya®
05.03.01 Restricted Use Cancer Drugs Fund Tenofovir and Emtricitabine 
05.03.01 Restricted Use Cancer Drugs Fund Tenofovir Disproxil 
05.03.01 Restricted Use Cancer Drugs Fund Tenofovir, cobicistat, elvitegravir & emtricitabine Stribild®
08.02.04 Restricted Use Cancer Drugs Fund Teriflunomide Aubagio®
06.06.01 Restricted Use Cancer Drugs Fund Teriparatide Forsteo®
06.06.01 Restricted Use Cancer Drugs Fund Teriparatide Movymia®
20 Formulary Cancer Drugs Fund TETRAHYDROBIOPTERIN Tablets 10 mg 
03.07 Formulary Cancer Drugs Fund Tezacaftor + Ivacaftor Symkevi®
08.02.04 Restricted Use Cancer Drugs Fund Thalidomide Celgene®
13.05.03 Restricted Use Cancer Drugs Fund Tildrakizumab Ilumetri®
05.03.01 Restricted Use Cancer Drugs Fund Tipranavir Aptivus®
08.01 Restricted Use Cancer Drugs Fund Tivozanib Fotivda®
05.01.04 Restricted Use Cancer Drugs Fund Tobramycin 
05.01.04 Restricted Use Cancer Drugs Fund Tobramycin inhaler TOBI Podhaler®
10.01.03 Restricted Use Cancer Drugs Fund Tocilizumab RoActemra®
10.01.03 Restricted Use Cancer Drugs Fund Tofacitinib citrate 
06.05.02 Restricted Use Cancer Drugs Fund Tolvaptan Jinarc®
06.05.02 Non Formulary Cancer Drugs Fund Tolvaptan Samsca®
08.01.05 Restricted Use Cancer Drugs Fund Trametinib Mekinist®
08.01.05 Formulary Cancer Drugs Fund Trastuzumab Herceptin®
08.01.05 Restricted Use Cancer Drugs Fund Trastuzumab Herceptin®
08.01.05 Restricted Use Cancer Drugs Fund Trastuzumab Ontruzant®
08.01.05 Restricted Use Cancer Drugs Fund Trastuzumab emtansine Kadcyla®
20 Non Formulary Cancer Drugs Fund Treprostinil  
08.01.05 Restricted Use Cancer Drugs Fund Trifluridine-tipiracil Lonsurf®
13.05.03 Formulary Cancer Drugs Fund Ustekinumab 
05.03.02.02 Restricted Use Cancer Drugs Fund Valganciclovir 
01.05.03 Restricted Use Cancer Drugs Fund Vedolizumab Entyvio®
08.01.05 Restricted Use Cancer Drugs Fund Vemurafenib Zelboraf®
08.01.05 Restricted Use Cancer Drugs Fund Venetoclax Venclyxto®
11.08.02 Restricted Use Cancer Drugs Fund Verteporfin Visudyne®
08.01.05 Restricted Use Cancer Drugs Fund Vismodegib Erivedge®
02.11 Restricted Use Cancer Drugs Fund Von willebrand factor Willfact®
05.02 Restricted Use Cancer Drugs Fund Voriconazole Vfend®
08.01.05 Restricted Use Cancer Drugs Fund Vosaroxin Qinprezo
05.03.01 Restricted Use Cancer Drugs Fund Zidovudine Retrovir®
05.03.01 Formulary Cancer Drugs Fund Zidovudine and lamivudine 
Nottinghamshire Area Prescribing Committee